The Cbl protooncoprotein: a negative regulator of immune receptor signal transduction
- 1 August 1999
- journal article
- review article
- Published by Elsevier in Immunology Today
- Vol. 20 (8) , 375-382
- https://doi.org/10.1016/s0167-5699(99)01484-x
Abstract
No abstract availableKeywords
This publication has 61 references indexed in Scilit:
- Xid -Like Immunodeficiency in Mice with Disruption of the p85α Subunit of Phosphoinositide 3-KinaseScience, 1999
- Cbl-mediated Negative Regulation of the Syk Tyrosine KinaseJournal of Biological Chemistry, 1998
- Lymphocyte signalling: A coordinating role for Vav?Current Biology, 1998
- Impaired Plasma Membrane Targeting of Grb2–Murine Son of Sevenless (mSOS) Complex and Differential Activation of the Fyn–T Cell Receptor (TCR)-ζ–Cbl Pathway Mediate T Cell Hyporesponsiveness in Autoimmune Nonobese Diabetic MiceThe Journal of Experimental Medicine, 1997
- The Cbl Protooncogene Product: From an Enigmatic Oncogene to Center Stage of Signal TransductionCritical Reviews™ in Oncogenesis, 1997
- Complex Complexes: Signaling at the TCRImmunity, 1996
- A Novel Phosphotyrosine-binding Domain in the N-terminal Transforming Region of Cbl Interacts Directly and Selectively with ZAP-70 in T CellsJournal of Biological Chemistry, 1996
- Upstream-Downstream: CD28 Cosignaling Pathways and T Cell FunctionImmunity, 1996
- Blocked Ras Activation in Anergic CD4 + T CellsScience, 1996
- Activation-Induced Ubiquitination of the T Cell Antigen ReceptorScience, 1992